IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $198,944 | -21.1% | 43,724 | +22.1% | 0.01% | -22.2% |
| Q2 2023 | $252,166 | +8.7% | 35,819 | -5.7% | 0.01% | -10.0% |
| Q1 2023 | $231,966 | +29.3% | 37,965 | +35.2% | 0.01% | +11.1% |
| Q4 2022 | $179,470 | -99.9% | 28,086 | +1.5% | 0.01% | -30.8% |
| Q3 2022 | $265,136,000 | +86545.8% | 27,676 | 0.0% | 0.01% | -7.1% |
| Q2 2022 | $306,000 | -34.1% | 27,676 | -0.7% | 0.01% | -22.2% |
| Q1 2022 | $464,000 | -2.7% | 27,882 | +11.6% | 0.02% | +12.5% |
| Q4 2021 | $477,000 | -12.3% | 24,989 | +13.3% | 0.02% | -20.0% |
| Q3 2021 | $544,000 | -13.1% | 22,062 | -8.3% | 0.02% | -9.1% |
| Q2 2021 | $626,000 | +203.9% | 24,072 | +270.5% | 0.02% | +175.0% |
| Q1 2021 | $206,000 | – | 6,497 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |